TNF계 CD137L 및 RANKL의 파골세포와 T 세포에 대한 활성조절
STUDY ON THE REGULATION OF OSTEOCLAST AND T CELL ACTIVATION VIA CELL MEMBRANE PROTEINS OF TNF FAMILY, CD137 LIGAND AND RANK LIGAND
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
본 연구는 TNFR family인 CD137 및 RANK, 파골세포의 CD137L와 T 세포의 RANKL 간의 역신호에 의한 이들 세포 의 역할을 알아보고자 하였다. 이에 RANKL 및 CD137L 자극으로 유도되는 역신호 전달에 의한 T 세포 활성과 파골세포분 화에 미치는 영향을 규명하고자 웅성 생쥐의 골수세포와 T 세포를 공동배양하여 다음과 같은 결과를 얻었다. 1. 생쥐 단핵세포주 및 골수유도 단핵전구세포에서 CD137L이 발현되며, CD137L 단클론 항체로 자극을 주었을 경우 파 골세포 표지단백질인 TRAP 양성 파골세포의 형성이 억제되었다. 2. 활성화된 CD4+ 및 CD8+ T 세포에서 RANKL을 발현하였으며 RANKL의 유사 수용체인 OPG 재조합 단백질을 처리 하여 CD4+ 및 CD8+ T 세포의 세포증식이 억제되었다. 이 연구의 결과는 CD137 자극에 의한 T 세포활성 및 RANK 자극에 의한 파골세포분화 및 활성이 각각 수용체에 결합하 는 라이겐드의 역신호에 의해 억제되었는데, 이는 파골세포와 T 세포의 과도한 활성을 제어하는 생체의 항상성조절에 관여하 는 기전으로 생각된다.
Abstract
Resorption of alveolar bone in periodontitis is due to excessive differentiation and activation of osteoclasts. Bacterial antigens causing periodontitis activates CD4 T cells, which leads to expressing RANK ligand (RANKL) on CD4 T cells. RANKL binds RANK on preosteoclasts or osteoclasts, and enhances the differentiation preosteoclasts into osteoclasts and the activation of mature osteoclasts. CD137, one of TNF receptor (TNFR) family, expressed on activated T cells binds with CD137 ligand (CD137L) on antigen presenting cells. Cross-linking of CD137 by CD137L acts as T cell co-stimulatory signals and, therefore, enhances the activation of T cell. In this study, I elucidated the biological responses of CD137L on (pre)osteoclasts and RANKL on T cells in the context of in vivo interaction between T cells and osteoclasts. RAW264.7, murine monocytic cells, constitutively express CD137L. Ligation of CD137L with anti-CD137L mAb inhibited RANKL-induced osteoclast formation in a dosedependent manner. Bone marrow cells are expressed CD137L by the treatment with M-CSF. Cross-linking of CD137L abolished M-CSF/ RANKL-evoked the formation of multi-nucleated osteoclasts. Both mouse CD4 and CD8 T cells are expressed RANKL following their activation. Ligation of RANKL with OPG, the decoy receptor for RANKL, inhibited both CD4 and CD8 T cell proliferation. These effects were attributed to RANKL-induced apoptosis. These data indicate that CD137L and RANKL on osteoclasts and T cells, respectively provide them with inhibitory signal.
참고문헌 (28)
- Chambers TJ, "Regulation of the differentiation and function of osteoclasts", J Pathol, 192, pp.4~13 (2000)
- Teitlelbaum SL, "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)
- Rodan GA, "Therapeutic approaches to bone diseases", Science, 289, pp.1508~1514 (2000)
- Takahashi N, "Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures", Endocrinology, 122, pp.1373~1382 (1988)
- Khosla S, "Minireview: the OPG", RANKL, Endocrinology, pp.2001, 142[DOI]
- Kawai T, "B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease", Am J Pathol, 9, pp.87~98 (2006)
- Erciyas K, "The changes in T lymphocyte subsets following periodontal treatment in patients with chronic periodontitis", J Periodontal Res, 41, pp.165~170 (2006)
- Brunetti G, "T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients", J Periodontol, 76, pp.1675~1680 (2005)
- Sun Y, "of Th2- mediated allergic airway inflammatory disease by CD137 costimulation", J Immunol, 177, pp.814~821 (2006)
- Lee HW, "4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1", J Immunol, 169, pp.4882~4888 (2002)
- Lee HW, "4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1", Eur J Immunol, 33, pp.2133~2141 (2003)
- Lee HW, "4-1BB crosslinking enhances the survival and cell cycle progression of CD4 T lymphocytes", Cell Immunol, 223, pp.143~150 (2003)
- Nam KO, "Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes", J Immunol, 174, pp.1898~1905 (2005)
- Saito K, "Infectionindued upregulation of the costimulatory molecule 4- 1BB in osteoblastic cells and its inhibitory effect on M-CSF", RANKL-induced in vitro osteoclastogenesis, 2004, pp.279, 13555~13563
- Watts AD, "A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’", EMBO J, 18, pp.2119~2126 (1999)
- Yasuda H, "Osteoclast differentiation factor is a ligand for osteoprotegerin", osteoclastogenesis-inhibitory factor and is identical to TRANCE, Proc Natl Acad Sci. USA, pp.1998, 95[DOI]
- Lacey DL, "Oste-oprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)
- Nakagawa N, "RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis", Biochem Biophys Res Commun, 253, pp.395~400 (1998)
- Marks SC Jr, "Osteoclast biology: Lessons from mammalian mutations", Am. J Med Genet, 34, pp.43~53 (1989)
- McLean W, "Mouse models of abnormal skeletal development and homeostasis", Trends Genet, 17, pp.S38~S43 (2001)
- Simonet WS, "Osteoprotegerin: A novel secreted protein involved in the regulation of bone density", Cell, 89, pp.309~319 (1997)
- Yasuda H, "Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG", OCIF inhibits osteoclastogenesis in vitro, 1998, pp.139, 1329~1337
- Morony S, "A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1, TNF-alpha, PTH, PTHrP, and 1,25(OH)2D3", J Bone Miner Res, 14, pp.1478~1485 (1999)
- Anderson DM, "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function", Nature, 390, pp.175~179 (1997)
- Li J, "RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism", Proc Natl Acad Sci USA, 97, pp.1566~1571 (2000)
- Hofbauer LC, "The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption", J Bone Miner Res, 15, pp.2~12 (2000)
- Theill LE, "RANK-L and RANK: T cells, bone loss, and mammalian evolution", Annu Rev Immunol, 20, pp.795~823 (2002)
- Udagawa N, "Osteoprotegerin produced by osteoblasts is an impor", ~